Laboratory Medicine ›› 2026, Vol. 41 ›› Issue (2): 177-181.DOI: 10.3969/j.issn.1673-8640.2026.02.012
Previous Articles Next Articles
ZHANG Jia1, WU Qing2, ZHANG Ying3, XU Kai1, CHEN Yangfang1, ZOU He4(
)
Received:2024-04-04
Revised:2025-03-16
Online:2026-02-28
Published:2026-03-06
CLC Number:
ZHANG Jia, WU Qing, ZHANG Ying, XU Kai, CHEN Yangfang, ZOU He. Serotype,drug resistance and virulence genes of invasive group B Streptococcus in newborns in Wenzhou[J]. Laboratory Medicine, 2026, 41(2): 177-181.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2026.02.012
| 血清型 | ST12 | ST17 | ST529 | ST862 | 少见分型(未分型) |
|---|---|---|---|---|---|
| Ⅰa | 0(0) | 0(0) | 0(0) | 0(0) | 4(100.0) |
| Ⅰb | 7(58.4) | 0(0) | 0(0) | 0(0) | 5(41.6) |
| Ⅲ-1 | 0(0) | 0(0) | 1(25.0) | 0(0) | 3(75.0) |
| Ⅲ-2 | 0(0) | 13(92.9) | 0(0) | 0(0) | 1(7.1) |
| Ⅲ-3 | 0(0) | 0(0) | 0(0) | 5(71.4) | 2(28.6) |
| Ⅴ | 0(0) | 0(0) | 5(41.0) | 0(0) | 7(59.0) |
| Ⅵ | 0(0) | 0(0) | 0(0) | 0(0) | 1(100.0) |
| 血清型 | ST12 | ST17 | ST529 | ST862 | 少见分型(未分型) |
|---|---|---|---|---|---|
| Ⅰa | 0(0) | 0(0) | 0(0) | 0(0) | 4(100.0) |
| Ⅰb | 7(58.4) | 0(0) | 0(0) | 0(0) | 5(41.6) |
| Ⅲ-1 | 0(0) | 0(0) | 1(25.0) | 0(0) | 3(75.0) |
| Ⅲ-2 | 0(0) | 13(92.9) | 0(0) | 0(0) | 1(7.1) |
| Ⅲ-3 | 0(0) | 0(0) | 0(0) | 5(71.4) | 2(28.6) |
| Ⅴ | 0(0) | 0(0) | 5(41.0) | 0(0) | 7(59.0) |
| Ⅵ | 0(0) | 0(0) | 0(0) | 0(0) | 1(100.0) |
| 抗菌药物 | ST12 | ST17 | ST529 | ST862 | 其他 | P值 |
|---|---|---|---|---|---|---|
| 左氧氟沙星 | 29(2/7) | 0(0/13) | 17(1/6) | 40(2/5) | 26(6/23) | 0.14 |
| 克林霉素 | 57(4/7) | 38(5/13) | 100(6/6) | 60(3/5) | 57(13/23) | 0.16 |
| 四环素 | 86(6/7) | 92(12/13) | 100(6/6) | 0(0/5) | 78(18/23) | 0.80 |
| 青霉素 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 氨苄西林 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 利奈唑胺 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 万古霉素 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 抗菌药物 | ST12 | ST17 | ST529 | ST862 | 其他 | P值 |
|---|---|---|---|---|---|---|
| 左氧氟沙星 | 29(2/7) | 0(0/13) | 17(1/6) | 40(2/5) | 26(6/23) | 0.14 |
| 克林霉素 | 57(4/7) | 38(5/13) | 100(6/6) | 60(3/5) | 57(13/23) | 0.16 |
| 四环素 | 86(6/7) | 92(12/13) | 100(6/6) | 0(0/5) | 78(18/23) | 0.80 |
| 青霉素 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 氨苄西林 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 利奈唑胺 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 万古霉素 | 0(0/7) | 0(0/13) | 0(0/6) | 0(0/5) | 0(0/23) | 1.00 |
| 毒力基因 | ST12 | ST17 | ST529 | ST862 | 其他(未分型?) | P值 |
|---|---|---|---|---|---|---|
| Srr-2 | 0(0/7) | 100(13/13) | 0(0/6) | 0(0/5) | 8.7(2/23) | <0.001 |
| cba | 57(4/7) | 0(0/13) | 0(0/6) | 0(0/5) | 22(5/23) | 0.015 |
| fbsA | 100(7/7) | 100(13/13) | 17(1/6) | 60(3/5) | 74(17/23) | <0.001 |
| fbsB | 0(0/7) | 100(13/13) | 0(0/6) | 0(0/5) | 35(8/23) | <0.001 |
| lmb | 100(7/7) | 100(13/13) | 83(5/6) | 0(0/5) | 96(22/23) | <0.001 |
| rib | 0(0/7) | 100(13/13) | 83(5/6) | 0(0/5) | 35(8/23) | <0.001 |
| 毒力基因 | ST12 | ST17 | ST529 | ST862 | 其他(未分型?) | P值 |
|---|---|---|---|---|---|---|
| Srr-2 | 0(0/7) | 100(13/13) | 0(0/6) | 0(0/5) | 8.7(2/23) | <0.001 |
| cba | 57(4/7) | 0(0/13) | 0(0/6) | 0(0/5) | 22(5/23) | 0.015 |
| fbsA | 100(7/7) | 100(13/13) | 17(1/6) | 60(3/5) | 74(17/23) | <0.001 |
| fbsB | 0(0/7) | 100(13/13) | 0(0/6) | 0(0/5) | 35(8/23) | <0.001 |
| lmb | 100(7/7) | 100(13/13) | 83(5/6) | 0(0/5) | 96(22/23) | <0.001 |
| rib | 0(0/7) | 100(13/13) | 83(5/6) | 0(0/5) | 35(8/23) | <0.001 |
| [1] |
CHAN Y T V, LAU S Y F, HUI S Y A, et al. Incidence of neonatal sepsis after universal antenatal culture-based screening of group B Streptococcus and intrapartum antibiotics:a multicentre retrospective cohort study[J]. BJOG, 2023, 130(1):24-31.
DOI URL |
| [2] |
PUOPOLO K M, LYNFIELD R, CUMMINGS J J, et al. Management of infants at risk for group B streptococcal disease[J]. Pediatrics, 2019, 144(2):e20191881.
DOI URL |
| [3] | 关小珊, 刘海英, 钟华敏, 等. 广州地区低龄婴儿侵袭性B族链球菌的发病率及临床特征[J]. 中华实用儿科临床杂志, 2016, 31(10):765-768. |
| [4] |
YING Q, WANG S, LOU X, et al. Burden and risk factors of invasive group B Streptococcus disease among neonates in a Chinese maternity hospital[J]. BMC Infect Dis, 2019, 19(1):123.
DOI |
| [5] |
HSU J F, LU J J, CHU S M, et al. The clinical and genetic characteristics of Streptococcus agalactiae meningitis in neonates[J]. Int J Mol Sci, 2023, 24(20):15387.
DOI URL |
| [6] | 郭孟杨, 高薇, 袁林, 等. 新生儿B族链球菌感染流行病学和预防策略近十年来的研究进展[J]. 中国当代儿科杂志, 2023, 25(5):534-540. |
| [7] | 王超, 赵扬玉. 规范临床用药,改善母婴结局:美国《预防新生儿早发型B族链球菌病:ACOG委员会共识》解读[J]. 协和医学杂志, 2020, 11(4):402-407. |
| [8] |
TEATERO S, FERRIERI P, MARTIN I, et al. Serotype distribution, population structure,and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women[J]. J Clin Microbiol, 2017, 55(2):412-422.
DOI URL |
| [9] | SUNKARA B, BHEEMREDDY S, LORBER B, et al. Group B Streptococcus infections in non-pregnant adults:the role of immunosuppression[J]. Int J Infect Dis, 2012, 16(3):e182-e186. |
| [10] |
EL-GENDY A A, HASSAN S E T, GERTZ B, et al. Serotyping and antibiotic susceptibility of invasive Streptococcus agalactiae in Egyptian patients with or without diabetes mellitus[J]. Am J Trop Med Hyg, 2021, 105(6):1684-1689.
DOI URL |
| [11] |
MOHAMED N A, HINGE M, LARSEN O H, et al. Streptococcus agalactiae do not penetrate human chorioamniotic membranes in vitro but alter their biomechanical properties[J]. Acta Obstet Gynecol Scand, 2021, 100(10):1814-1821.
DOI URL |
| [12] | 中华医学会儿科学分会新生儿学组, 中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019年版)[J]. 中华儿科杂志, 2019, 57(4):252-257. |
| [13] | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial suscepitibility testing[S]. M100,CLSI, 2022. |
| [14] | CHEN S, ZHOU Y, CHEN Y, et al. Fastp:an ultra-fast all-in-one FASTQ preprocessor[J]. Bioinformatics, 2018, 34(17):i884-i890. |
| [15] |
PRJIBELSKI A, ANTIPOV D, MELESHKO D, et al. Using SPAdes de novo assembler[J]. Curr Protoc Bioinformatics, 2020, 70(1):e102.
DOI URL |
| [16] |
SEEMANN T. Prokka:rapid prokaryotic genome annotation[J]. Bioinformatics, 2014, 30(14):2068-2069.
DOI URL |
| [17] | LETUNIC I, BORK P. Interactive tree of life(iTOL)v3:an online tool for the display and annotation of phylogenetic and other trees[J]. Nucleic Acids Res, 2016, 44(W1):W242-W245. |
| [18] | 段道云, 刘雨露, 王战胜, 等. 2019—2022年某院新生儿无乳链球菌医院感染血清分型及其流行病学[J]. 中华医院感染学杂志, 2023, 33(21):3292-3296. |
| [19] |
LANCASTER H, ROBERTS A P, BEDI R, et al. Characterization of Tn916S,a Tn916-like element containing the tetracycline resistance determinant tet(S)[J]. J Bacteriol, 2004, 186(13):4395-4398.
DOI URL |
| [20] |
WENDLANDT S, LI B, LOZANO C, et al. Identification of the novel spectinomycin resistance gene spw in methicillin-resistant and methicillin-susceptible Staphylococcus aureus of human and animal origin[J]. J Antimicrob Chemother, 2013, 68(7):1679-1680.
DOI URL |
| [21] |
TENENBAUM T, SPELLERBERG B, ADAM R, et al. Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb[J]. Microbes Infect, 2007, 9(6):714-720.
DOI URL |
| [22] | PRACHT D, ELM C, GERBER J, et al. PavA of Streptococcus pneumoniae modulates adherence,invasion,and meningeal inflammation[J]. Infect Immun, 2005, 73(5):2680-2689. |
| [23] | BOHNSACK J F, MOLLISON K W, BUKO A M, et al. Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus[J]. Biochem J, 1991, 273(Pt 3):635-640. |
| [24] |
DORAN K S, CHANG J C, BENOIT V M, et al. Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8[J]. J Infect Dis, 2002, 185(2):196-203.
PMID |
| [25] |
RING A, BRAUN J S, NIZET V, et al. Group B streptococcal beta-hemolysin induces nitric oxide production in murine macrophages[J]. J Infect Dis, 2000, 182(1):150-157.
PMID |
| [26] |
LANG S, PALMER M. Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin[J]. J Biol Chem, 2003, 278(40):38167-38173.
DOI URL |
| [27] |
ZHOU J, ZHANG L, ZHANG Y, et al. Analysis of molecular characteristics of CAMP-negative Streptococcus agalactiae strains[J]. Front Microbiol, 2023, 14:1189093.
DOI URL |
| [28] |
TSAI I A, SU Y, WANG Y H, et al. Alterations in genes rib,scpB and Pilus Island decrease the prevalence of predominant serotype Ⅴ,not Ⅲ and Ⅵ,of Streptococcus agalactiae from 2008 to 2012[J]. Pathogens, 2022, 11(10):1145.
DOI URL |
| [29] | LARTIGUE M F, POULARD A F, AL SAFADI R, et al. Variability of neuD transcription levels and capsular sialic acid expression among serotype Ⅲ group B Streptococcus strains[J]. Microbiology(Reading), 2011, 157(Pt 12):3282-3291. |
| [30] | LEWIS A L, CAO H, PATEL S K, et al. NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus[J]. J Biol Chem, 2007, 282(38):27562-27571. |
| [1] | YANG Chengfan, HAN Liang, LI Weixia, SHI Jian, LI Xue, LU Shuhua. Research progress of Streptococcus pneumoniae [J]. Laboratory Medicine, 2026, 41(2): 196-201. |
| [2] | YANG Shu, YANG Lihua, SHENG Fengsong, JIANG Yonggen, QIAO Xuefei, ZHU Tianyue, YU Zifan, TANG Yiming. Drug resistance genes,virulence genes and molecular typing characteristics of 101 isolates of Campylobacter based on whole genome sequencing [J]. Laboratory Medicine, 2025, 40(7): 673-679. |
| [3] | BAO Rong, SHEN Jiajin, YAO Yumeng, MIAO Qing, WANG Beili, PAN Baishen, GUO Wei, HU Bijie. Distribution and drug resistance of clinical rapidly growing Mycobacterium in a Grade 3 Class A hospital [J]. Laboratory Medicine, 2025, 40(6): 540-544. |
| [4] | SUN Gang, SUN Hui, BAO Lina, LIU Xianwei, LU Mingyang, LIU Jing, TIAN Yuan. Drug resistance and molecular epidemiology of OS-MRSA in Hulunbuir,Inner Mongolia [J]. Laboratory Medicine, 2025, 40(6): 551-554. |
| [5] | YAO Ling, GAO Chunyan, LIU Minglei. Virulence characteristics of Streptococcus pneumoniae,PBP gene mutation and β-lactam resistance [J]. Laboratory Medicine, 2025, 40(5): 450-454. |
| [6] | CUI Lanying, GUO Dawen, YU Xiaochen, WANG Xi. Distribution characteristics and drug resistance analysis of fungi isolated from clinical samples from 2019 to 2023 in Heilongjiang [J]. Laboratory Medicine, 2025, 40(10): 1014-1018. |
| [7] | GUO Chaonan, WANG Yanyan, ZHANG Bei, PANG Jingying, CUI Feifei, ZHAO Yongxin, SU Bing. Analysis of drug resistance and virulence of Klebsiella pneumoniae from different clinical samples [J]. Laboratory Medicine, 2024, 39(9): 880-887. |
| [8] | WANG Yawen, ZHANG Yingying, NIU Wenyan. Influence of glycated hemoglobin A1c on pathogens of urinary tract infection in patients with type 2 diabetes mellitus [J]. Laboratory Medicine, 2024, 39(9): 895-899. |
| [9] | WANG Xuqin, LIN Qianru, FENG Wanqing, DONG Yuan, YU Xiaolei, LIU Changhe, NING Zhen, SHEN Xin, PAN Qichao, LIN Yi. Validation of HIV-1 integrase genotyping sequence assay [J]. Laboratory Medicine, 2024, 39(4): 369-375. |
| [10] | ZHAO Yanan, XIAO Weili, CAO Qixin, YAN Yan, CUI Xiuge, ZHAO Jianping. Relation of drug resistance,serotypes and genotypes of Group B Streptococcus in perinatal pregnant females and pregnancy outcomes [J]. Laboratory Medicine, 2024, 39(4): 382-386. |
| [11] | DUAN Xuehan, WU Hua. Application of MALDI-TOF MS technology in clinical microbiological examination [J]. Laboratory Medicine, 2024, 39(4): 410-414. |
| [12] | YU Feng, HU Longhua, XIAO Yanping, YANG Junping. Virulence genes and molecular characteristics of Klebsiella pneumoniae isolated from bloodstream infection patients [J]. Laboratory Medicine, 2024, 39(3): 249-255. |
| [13] | CHEN Yu, ZHAO Ya, WANG Lin. Microbial distribution and drug resistance in chronic dacryocystitis [J]. Laboratory Medicine, 2024, 39(3): 256-259. |
| [14] | CHEN Huan, DONG Fang, LÜ Zhiyong, ZHEN Jinghui, CHEN Mei, SU Jianrong. Serotypes and drug resistance of invasive Streptococcus agalactiae in children [J]. Laboratory Medicine, 2024, 39(3): 260-264. |
| [15] | MA Chen, ZHANG Yi, LI Fang, WANG Jing, CHEN Wei. Clinical characteristics,drug resistance and poor prognosis factors in children with invasive pneumococcal disease with necrotizing pneumonia [J]. Laboratory Medicine, 2024, 39(3): 265-271. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||